vs
Side-by-side financial comparison of SBC Medical Group Holdings Inc (SBC) and SIFCO INDUSTRIES INC (SIF). Click either name above to swap in a different company.
SBC Medical Group Holdings Inc is the larger business by last-quarter revenue ($39.6M vs $24.0M, roughly 1.7× SIFCO INDUSTRIES INC). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs 7.5%, a 28.4% gap on every dollar of revenue. On growth, SIFCO INDUSTRIES INC posted the faster year-over-year revenue change (14.8% vs -10.9%). SBC Medical Group Holdings Inc produced more free cash flow last quarter ($51.2M vs $8.0M). Over the past eight quarters, SIFCO INDUSTRIES INC's revenue compounded faster (8.1% CAGR vs -15.0%).
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
SIFCO Industries, Inc. (SIFCO), is a global metal component manufacturer based in Cleveland, Ohio.
SBC vs SIF — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $39.6M | $24.0M |
| Net Profit | $14.2M | $1.8M |
| Gross Margin | 73.1% | 21.6% |
| Operating Margin | 32.5% | 10.7% |
| Net Margin | 35.9% | 7.5% |
| Revenue YoY | -10.9% | 14.8% |
| Net Profit YoY | 117.2% | 177.3% |
| EPS (diluted) | $0.15 | $0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $39.6M | $24.0M | ||
| Q3 25 | $43.4M | $22.8M | ||
| Q2 25 | $43.4M | $22.1M | ||
| Q1 25 | $47.3M | $19.0M | ||
| Q4 24 | $44.4M | $20.9M | ||
| Q3 24 | $53.1M | $21.7M | ||
| Q2 24 | $53.1M | $22.0M | ||
| Q1 24 | $54.8M | $20.5M |
| Q4 25 | $14.2M | $1.8M | ||
| Q3 25 | $12.8M | $-429.0K | ||
| Q2 25 | $2.5M | $3.4M | ||
| Q1 25 | $21.5M | $-1.4M | ||
| Q4 24 | $6.5M | $-2.3M | ||
| Q3 24 | $2.8M | $-443.0K | ||
| Q2 24 | $18.5M | $72.0K | ||
| Q1 24 | $18.8M | $-1.6M |
| Q4 25 | 73.1% | 21.6% | ||
| Q3 25 | 70.6% | 9.6% | ||
| Q2 25 | 69.2% | 26.7% | ||
| Q1 25 | 79.7% | 8.3% | ||
| Q4 24 | 76.3% | 4.4% | ||
| Q3 24 | 81.5% | 10.7% | ||
| Q2 24 | 74.2% | 12.3% | ||
| Q1 24 | 72.1% | 7.3% |
| Q4 25 | 32.5% | 10.7% | ||
| Q3 25 | 36.6% | -1.7% | ||
| Q2 25 | 33.6% | 14.8% | ||
| Q1 25 | 51.1% | -4.1% | ||
| Q4 24 | 10.6% | -9.2% | ||
| Q3 24 | 26.1% | -1.5% | ||
| Q2 24 | 51.4% | 0.7% | ||
| Q1 24 | 44.6% | -6.5% |
| Q4 25 | 35.9% | 7.5% | ||
| Q3 25 | 29.6% | -1.9% | ||
| Q2 25 | 5.7% | 15.4% | ||
| Q1 25 | 45.4% | -7.3% | ||
| Q4 24 | 14.7% | -11.1% | ||
| Q3 24 | 5.3% | -2.0% | ||
| Q2 24 | 34.8% | 0.3% | ||
| Q1 24 | 34.2% | -7.8% |
| Q4 25 | $0.15 | $0.29 | ||
| Q3 25 | $0.12 | $-0.07 | ||
| Q2 25 | $0.02 | $0.56 | ||
| Q1 25 | $0.21 | $-0.23 | ||
| Q4 24 | $0.05 | $-0.38 | ||
| Q3 24 | $0.03 | $-0.07 | ||
| Q2 24 | $0.20 | $0.01 | ||
| Q1 24 | $0.20 | $-0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $164.1M | $1.1M |
| Total DebtLower is stronger | $42.8M | $39.0K |
| Stockholders' EquityBook value | $248.3M | $38.7M |
| Total Assets | $380.4M | $74.9M |
| Debt / EquityLower = less leverage | 0.17× | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $164.1M | $1.1M | ||
| Q3 25 | $127.4M | $491.0K | ||
| Q2 25 | $152.7M | $2.0M | ||
| Q1 25 | $132.1M | $1.9M | ||
| Q4 24 | $125.0M | $3.1M | ||
| Q3 24 | $137.4M | $1.7M | ||
| Q2 24 | — | $3.4M | ||
| Q1 24 | — | $2.5M |
| Q4 25 | $42.8M | $39.0K | ||
| Q3 25 | $21.1M | $51.0K | ||
| Q2 25 | $7.1M | — | ||
| Q1 25 | $6.9M | — | ||
| Q4 24 | $6.6M | — | ||
| Q3 24 | $823.2K | $0 | ||
| Q2 24 | — | $3.6M | ||
| Q1 24 | — | $4.1M |
| Q4 25 | $248.3M | $38.7M | ||
| Q3 25 | $248.0M | $36.9M | ||
| Q2 25 | $244.6M | $35.8M | ||
| Q1 25 | $226.4M | $32.4M | ||
| Q4 24 | $195.1M | $33.7M | ||
| Q3 24 | $205.0M | $30.4M | ||
| Q2 24 | $8.8M | $29.8M | ||
| Q1 24 | $9.0M | $29.7M |
| Q4 25 | $380.4M | $74.9M | ||
| Q3 25 | $321.4M | $73.4M | ||
| Q2 25 | $315.3M | $77.3M | ||
| Q1 25 | $284.6M | $78.8M | ||
| Q4 24 | $266.1M | $81.0M | ||
| Q3 24 | $296.5M | $104.6M | ||
| Q2 24 | $19.5M | $106.3M | ||
| Q1 24 | $19.8M | $104.2M |
| Q4 25 | 0.17× | 0.00× | ||
| Q3 25 | 0.09× | 0.00× | ||
| Q2 25 | 0.03× | — | ||
| Q1 25 | 0.03× | — | ||
| Q4 24 | 0.03× | — | ||
| Q3 24 | 0.00× | 0.00× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | — | 0.14× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $52.0M | $8.1M |
| Free Cash FlowOCF − Capex | $51.2M | $8.0M |
| FCF MarginFCF / Revenue | 129.3% | 33.3% |
| Capex IntensityCapex / Revenue | 2.0% | 0.4% |
| Cash ConversionOCF / Net Profit | 3.66× | 4.51× |
| TTM Free Cash FlowTrailing 4 quarters | $23.3M | $11.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $52.0M | $8.1M | ||
| Q3 25 | $-20.9M | $726.0K | ||
| Q2 25 | $-8.3M | $371.0K | ||
| Q1 25 | $1.9M | $2.8M | ||
| Q4 24 | $-7.3M | $-3.8M | ||
| Q3 24 | $5.0M | $857.0K | ||
| Q2 24 | $19.2M | $382.0K | ||
| Q1 24 | $3.7M | $-3.2M |
| Q4 25 | $51.2M | $8.0M | ||
| Q3 25 | $-20.9M | $566.0K | ||
| Q2 25 | $-8.6M | $310.0K | ||
| Q1 25 | $1.7M | $2.7M | ||
| Q4 24 | $-7.9M | $-3.9M | ||
| Q3 24 | $4.6M | $580.0K | ||
| Q2 24 | $18.3M | $-175.0K | ||
| Q1 24 | $3.0M | $-3.9M |
| Q4 25 | 129.3% | 33.3% | ||
| Q3 25 | -48.3% | 2.5% | ||
| Q2 25 | -19.9% | 1.4% | ||
| Q1 25 | 3.5% | 14.1% | ||
| Q4 24 | -17.8% | -18.8% | ||
| Q3 24 | 8.7% | 2.7% | ||
| Q2 24 | 34.5% | -0.8% | ||
| Q1 24 | 5.4% | -18.9% |
| Q4 25 | 2.0% | 0.4% | ||
| Q3 25 | 0.1% | 0.7% | ||
| Q2 25 | 0.7% | 0.3% | ||
| Q1 25 | 0.5% | 0.8% | ||
| Q4 24 | 1.3% | 0.5% | ||
| Q3 24 | 0.8% | 1.3% | ||
| Q2 24 | 1.6% | 2.5% | ||
| Q1 24 | 1.3% | 3.3% |
| Q4 25 | 3.66× | 4.51× | ||
| Q3 25 | -1.63× | — | ||
| Q2 25 | -3.39× | 0.11× | ||
| Q1 25 | 0.09× | — | ||
| Q4 24 | -1.12× | — | ||
| Q3 24 | 1.77× | — | ||
| Q2 24 | 1.04× | 5.31× | ||
| Q1 24 | 0.20× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
SIF
| Fixed Wing Aircraft Revenue | $10.5M | 44% |
| Commercial Revenue | $8.7M | 36% |
| Commercial Product And Other Revenue | $2.8M | 12% |
| Commercial Space | $1.1M | 5% |
| Other | $840.0K | 4% |
